Mastopexy Market By Type (Benelli Lift or Donut Lift, Crescent Breast Lift, Lollipop Lift, Anchor Breast Lift), By End Use (Hospitals, Speciality Clinics): Global Opportunity Analysis and Industry Forecast, 2021-2031

Mastopexy Market By Type (Benelli Lift or Donut Lift, Crescent Breast Lift, Lollipop Lift, Anchor Breast Lift), By End Use (Hospitals, Speciality Clinics): Global Opportunity Analysis and Industry Forecast, 2021-2031

A breast lift with implants, which is medically referred to as a mastopexy, is a plastic surgery procedure designed to elevate/reshape sagging breasts, enhance breast fullness, reposition drooping nipples, and improve breast symmetry. The procedure can involve the use of a breast implant to increase the volume of the breast. When there is mild sagging to the breasts, an implant alone can produce a rejuvenated appearance with only a minimal skin incision. Any incision, however, is expected to result in permanent scars. The procedure can restore a more youthful-looking shape to the breast.

Breast ptosis, sagging, or descent of the breast is a common occurrence with age or following pregnancy, breastfeeding, or weight loss. Ptosis can be classified using the Regnault classification system. This commonly used system describes ptosis by the relative position of the nipple–areolar complex (NAC) and the inframammary fold. As the breast enlarges with age, weight, or hormonal changes, the skin envelope, supporting ligaments, and ducts stretch. These then fail to retract when the volume decreases. As a result, breast position is lower on the chest wall, breast contour changes, and upper pole fullness is decreased. Mastopexy seeks to restore a youthful shape and contour of the breast by transposing the nipple-areolar complex (NAC) to a more desirable position on the breast mound. This can be accomplished through various approaches that differ with respect to skin incisions, parenchymal redistribution and fixation, auto-augmentation, or augmentation with implant. 

Some of the complications associated with breast lifts surgery are scar, changes in nipple or breast sensation, and loss of nipple or areola. 

Scars - can fade over time. Changes in nipple or breast sensation -this usually comes back within a couple of weeks, but it can sometimes be permanent. Breasts that are different shapes or sizes heal at a different pace and loss of nipple or areola- this is rare, but can happen if the procedure causes blood loss to the area.

The coronavirus disease 2019 (COVID-19) is a novel, rapidly changing pandemic. It has affected specialized medical services in unprecedented ways. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped, positive-sense, single-stranded RNA β-coronavirus. SARS-CoV-2, which causes the disease known as coronavirus disease 2019 (COVID-19), was first reported in late 2019 in Wuhan, China and has rapidly developed into a global pandemic and public health emergency. Surgical decision making, always the most important aspect of care has taken on an added layer of complexity in the face of the COVID-19 pandemic. Therefore, recommendations for breast reconstruction during COVID-19 was challenging.

The overall impact of COVID-19 remains negative in the initial phase of pandemic on mastopexy market, due to decline in number of surgical procedures. Although, the report based on survey conducted during the pandemic, by American Society of Plastic Surgeon, the 11% of women indicated they are more interested in cosmetic plastic surgery or non-surgical procedures now than before COVID-19, and the figure is even higher among women who have already had surgery or a procedure, which was around 24%, respectively. 

Also, 35% of women who have previously had at least one cosmetic surgical procedure or minimally invasive procedure, plan to spend significantly or somewhat more on treatments in 2021 than in 2020. Moreover, the surgical procedures require the routine use of reusable equipment with close contact with patients. This increases the risk of disease transmission. Therefore, the impact of COVID-19 remains negative during the initial phase of pandemic, but the growth of the mastopexy market has accelerated post-COVID. 

Factors such as rise in female geriatric population and increase in demands for aesthetic procedures are the major drivers that propel the growth of mastopexy market during the forecast period. 

According, to the United Census Bureau, the global-female-geriatric population is estimated to reach 4,139 million by 2030 from 3,601 million as recorded in 2015. Enhancing one’s self-esteem and body image is one of the many benefits of having breast augmentation surgery. Moreover, women older than 40 tend to experience loss of volume with a lot of excess skin on the breast due to childbirth or weight loss. Also, older women are typically more self-assured about their life and are often more financially secure than many younger women, which contributes to this growing trend. Therefore, due to increase in female population, the procedures of breast augmentation increase that also improves the physical appearance of women if they believe that their breasts are too large or too small. 

Moreover, growth of the healthcare infrastructure and rise in income levels in developing countries such as China, India, and Brazil, are contributing to the rise in demand for cosmetic breast lifting procedures. 

Post-surgery complications such as scar, changes in nipple or breast sensation and loss of nipple or areola, high cost of the surgical procedures and shortage of skilled workforce are expected to be the significant restraints to the market growth during the forecast period. A breast lift procedure can be costlier than a breast implant. The cost of breast lifting surgeries ranges between $9,000 and $16,000. On the other hand, the cost of breast implants ranges from $6,000 to $12,000. Silicone implants had been utilized in 84% and saline implants in 16% of all the breast augmentations in 2020.

The mastopexy market is segmented on the basis of type, end use and region. By type, the market is segmented into benelli lift or donut lift, crescent breast lift, lollipop lift and anchor breast lift mastopexy. 

On the basis of end use, the market is divided into hospitals and specialty clinics. 

Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major companies that operate in the mastopexy market are AbbVie, GC Aesthetics, Hologic, Mentor (Johnson & Johnson), Polytech Health & Aesthetics, Sientra Inc, Bausch Health, Establishment Labs, Lipoelastic and Guangzhou Wanhe Plastic Materials.

KEY BENEFITS FOR STAKEHOLDERS

This report entails a detailed quantitative analysis along with the current mastopexy market trends from 2022 to 2031 to identify the prevailing opportunities along with the strategic assessment.
The mastopexy market forecast is studied from 2022 to 2031.
The market size and estimations are based on a comprehensive analysis of key developments in the mastopexy industry.
A qualitative analysis based on innovative products facilitates strategic business planning.
The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the mastopexy market.

Key Market Segments

By Type

Benelli Lift or Donut Lift
Crescent Breast Lift
Lollipop Lift
Anchor Breast Lift

By End Use

Hospitals
Speciality Clinics

By Region

North America
U.S.
Canada
Mexico
Europe
France
United Kingdom
Italy
Spain
Rest of Europe
Germany
Asia-Pacific
China
Japan
India
Australia
Rest Of Asia Pacific
LAMEA
Brazil
Saudi Arabia
Colombia
Rest of LAMEA

Key Market Players

Abbvie Inc
BAUSCH HEALTH COMPANIES INC. (SOLTA MEDICAL)
Establishment Labs
GC Aesthetics
GUANGZHOU WANHE PLASTIC MATERIALS
Hologic, Inc.
JOHNSON & JOHNSON (MENTOR)
LIPOELASTIC
polytech health & aesthetics
Sientra Inc

Please Note: It will take 7-10 business days to complete the report upon order confirmation.